Related Experiment Video
Updated: May 31, 2025

07:17
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
10.3K
NON-FUNCTIONING SPORADIC PANCREATIC NEUROENDOCRINE TUMOR IS AN INDEPENDENT RISK FACTOR FOR RECURRENCE AFTER SURGICAL
Estela Regina Ramos Figueira1, André Luis Montagnini1, Jessica Okubo1
1Universidade de São Paulo, Faculty of Medicine - São Paulo (SP), Brazil.
Summary
Non-functioning pancreatic neuroendocrine tumors (NF-PNETs) are linked to higher recurrence rates after surgery. This highlights the need for closer monitoring of patients with small tumors, especially those undergoing conservative management.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Pathology
Background:
- Pancreatic neuroendocrine tumors (PNETs) are rare, heterogeneous neoplasms with increasing incidence.
- Non-functioning PNETs (NF-PNETs) constitute up to 80% of cases, often diagnosed via advanced imaging.
- Prognostic factors for PNET recurrence post-surgery remain incompletely understood.
Purpose of the Study:
- To identify prognostic risk factors and evaluate outcomes in surgically treated patients with sporadic PNETs.
- To determine the impact of tumor characteristics on disease recurrence.
- To inform clinical management and follow-up strategies for PNET patients.
Main Methods:
- Retrospective analysis of 113 patients with sporadic PNETs who underwent pancreatic resection.
- Data collection from medical records, including tumor type, grade, size, and patient demographics.
- Statistical analysis (univariate and multivariate) to identify independent prognostic factors for recurrence.
Main Results:
- NF-PNETs were identified as an independent prognostic risk factor for disease recurrence.
- Insulinomas were associated with younger patients, lower comorbidity burden, smaller tumors, and lower recurrence rates compared to other PNET types.
- Univariate analysis indicated age, tumor type, tumor size, and TNM staging as potential recurrence risk factors.
Conclusions:
- Non-functioning PNETs represent a significant independent risk factor for tumor recurrence.
- Findings support enhanced surveillance for patients with small tumors, particularly those managed conservatively.
- Further research into PNET heterogeneity and prognostic markers is warranted.

